Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Sell
33
VIAV Quote, Financials, Valuation and Earnings
Last price:
$9.26
Seasonality move
:
-1.27%
Day range:
$9.22 - $9.29
52-week range:
$6.60 - $12.91
Dividend yield:
0%
P/E ratio:
464.00x
P/S ratio:
1.99x
P/B ratio:
2.84x
Volume:
1.2M
Avg. volume:
2.5M
1-year change:
19.33%
Market cap:
$2.1B
Revenue:
$1B
EPS (TTM):
$0.02
Analysts' Opinion
-
Consensus RatingViavi Solutions has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 3 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $12.26, Viavi Solutions has an estimated upside of 32.14% from its current price of $9.26.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.60 representing 100% downside risk from its current price of $9.26.
Fair Value
-
According to the consensus of 8 analysts, Viavi Solutions has 32.14% upside to fair value with a price target of $12.26 per share.
VIAV vs. S&P 500
-
Over the past 5 trading days, Viavi Solutions has underperformed the S&P 500 by -3.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Viavi Solutions does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Viavi Solutions has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Viavi Solutions reported revenues of $284.8M.
Earnings Growth
-
Viavi Solutions earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Viavi Solutions reported earnings per share of $0.09.
Enterprise value:
2.3B
EV / Invested capital:
1.69x
Price / LTM sales:
1.99x
EV / EBIT:
49.17x
EV / Revenue:
2.21x
PEG ratio (5yr expected):
--
EV / Free cash flow:
35.03x
Price / Operating cash flow:
31.47x
Enterprise value / EBITDA:
21.83x
Gross Profit (TTM):
$603.2M
Return On Assets:
0.29%
Net Income Margin (TTM):
0.49%
Return On Equity:
0.73%
Return On Invested Capital:
0.38%
Operating Margin:
2.88%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.2B | $1B | $1B | $246M | $284.8M | |
| Gross Profit | $693.9M | $576.3M | $603.2M | $137.9M | $160.7M | |
| Operating Income | $128.8M | $39.4M | $51.8M | -$11.8M | $8.2M | |
| EBITDA | $184.6M | $118.6M | $106.1M | $6M | $26.7M | |
| Diluted EPS | $0.18 | -$0.02 | $0.02 | -$0.11 | $0.09 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1B | $1B | $1B | $867.6M | $835.4M | |
| Total Assets | $1.9B | $1.9B | $1.9B | $1.7B | $1.9B | |
| Current Liabilities | $273.1M | $259.7M | $412.6M | $227.8M | $544.7M | |
| Total Liabilities | $1.1B | $1.2B | $1.2B | $1B | $1.2B | |
| Total Equity | $811.8M | $709.9M | $682.3M | $705.1M | $728.8M | |
| Total Debt | $618.1M | $706.4M | $792.1M | $634.4M | $640.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $164.2M | $113.7M | $92.2M | $19.5M | $7.8M | |
| Cash From Investing | -$125.1M | -$49M | -$135.1M | -$6.9M | -$124.9M | |
| Cash From Financing | -$29.8M | -$194.6M | -$33.9M | -$97M | -$1.6M | |
| Free Cash Flow | $101.4M | $90.6M | $66.1M | $16.3M | $1M | |
VIAV
Sector
Market Cap
$2.1B
$80M
Price % of 52-Week High
71.9%
62.02%
Dividend Yield
0%
0%
Shareholder Yield
1.76%
0.9%
1-Year Price Total Return
19.9%
-14.14%
Beta (5-Year)
0.918
0.841
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$9.36
200-day SMA
Sell
Level
$9.86
Bollinger Bands (100)
Sell
Level
9.66 - 11.58
Chaikin Money Flow
Sell
Level
-2.1B
20-day SMA
Sell
Level
$9.68
Relative Strength Index (RSI14)
Sell
Level
37.65
ADX Line
Sell
Level
23.34
Williams %R
Neutral
Level
-58.4507
50-day SMA
Sell
Level
$10.28
MACD (12, 26)
Sell
Level
-0.29
25-day Aroon Oscillator
Sell
Level
-4
On Balance Volume
Sell
Level
-978.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-54.2022)
Sell
CA Score
(Annual)
Level (-0.685)
Buy
Beneish M-Score
(Annual)
Level (-2.9214)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.53)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.
Stock Forecast FAQ
In the current month, VIAV has received 4 Buy ratings 3 Hold ratings, and 1 Sell ratings. The VIAV average analyst price target in the past 3 months is $12.26.
-
Where Will Viavi Solutions Stock Be In 1 Year?
According to analysts, the consensus estimate is that Viavi Solutions share price will rise to $12.26 per share over the next 12 months.
-
What Do Analysts Say About Viavi Solutions?
Analysts are divided on their view about Viavi Solutions share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Viavi Solutions is a Sell and believe this share price will drop from its current level to $8.60.
-
What Is Viavi Solutions's Price Target?
The price target for Viavi Solutions over the next 1-year time period is forecast to be $12.26 according to 8 Wall Street analysts, 4 of them rate the stock a Buy, 1 rates the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is VIAV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Viavi Solutions is a Buy. 4 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of VIAV?
You can purchase shares of Viavi Solutions via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Viavi Solutions shares.
-
What Is The Viavi Solutions Share Price Today?
Viavi Solutions was last trading at $9.26 per share. This represents the most recent stock quote for Viavi Solutions. Yesterday, Viavi Solutions closed at $9.26 per share.
-
How To Buy Viavi Solutions Stock Online?
In order to purchase Viavi Solutions stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 24.59% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is up 22.13% over the past day.
